These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 17449927)
1. Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea. Song HJ; Kim TH; Song JH; Oh HJ; Ryu KH; Yeom HJ; Kim SE; Jung HK; Shim KN; Jung SA; Yoo K; Moon IH; Chung KW J Korean Med Sci; 2007 Apr; 22(2):218-22. PubMed ID: 17449927 [TBL] [Abstract][Full Text] [Related]
2. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. Hussain Z; Das BC; Husain SA; Murthy NS; Kar P J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154 [TBL] [Abstract][Full Text] [Related]
3. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Sohn YM; Rho HO; Park MS; Park JH; Choi BY; Ki M; Jang WI Yonsei Med J; 2000 Feb; 41(1):34-9. PubMed ID: 10731917 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain. Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy. John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469 [TBL] [Abstract][Full Text] [Related]
7. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [TBL] [Abstract][Full Text] [Related]
8. Current status of liver diseases in Korea: hepatitis A. Kwon SY Korean J Hepatol; 2009 Dec; 15 Suppl 6():S7-12. PubMed ID: 20037282 [TBL] [Abstract][Full Text] [Related]
9. Need for immunization against hepatotropic viruses in children with chronic liver disease. Srivastava A; Mathias A; Yachha SK; Agarwal J; Aggarwal R J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):393-7. PubMed ID: 24840513 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease]. de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease. Ramirez JC; Ackerman K; Strain SC; Ahmed ST; de Los Santos MJ; Sears D Hum Vaccin Immunother; 2016; 12(1):64-9. PubMed ID: 26836326 [TBL] [Abstract][Full Text] [Related]
12. Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. Younossi ZM; Stepanova M Hepatology; 2011 Oct; 54(4):1167-78. PubMed ID: 21725988 [TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. Acharya SK; Batra Y; Bhatkal B; Ojha B; Kaur K; Hazari S; Saraya A; Panda SK J Gastroenterol Hepatol; 2003 Jul; 18(7):822-7. PubMed ID: 12795755 [TBL] [Abstract][Full Text] [Related]
14. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Das A Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060 [TBL] [Abstract][Full Text] [Related]
16. Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination. Chen GJ; Lin KY; Sun HY; Sheng WH; Hsieh SM; Huang YC; Cheng A; Liu WC; Hung CC; Chang SC Liver Int; 2018 Apr; 38(4):594-601. PubMed ID: 28482131 [TBL] [Abstract][Full Text] [Related]
17. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India? Anand AC; Nagpal AK; Seth AK; Dhot PS J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855 [TBL] [Abstract][Full Text] [Related]
18. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. Sagnelli E; Stroffolini T; Almasio P; Mele A; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P J Viral Hepat; 2006 Jan; 13(1):67-71. PubMed ID: 16364085 [TBL] [Abstract][Full Text] [Related]
20. Increasing incidence of hepatitis A in Korean adults. Kim YJ; Lee HS Intervirology; 2010; 53(1):10-4. PubMed ID: 20068335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]